On-Demand Webinar: Systemic Mastocytosis - Insights Into A Rare Blood Disorder

Presented by guest speaker Dr. Alejandro Gru, MD, Professor of Dermatology and Director of Dermapathology at Columbia University’s Irving Medical Center, this webinar provides information about systemic mastocytosis, a rare blood disorder where abnormal mast cells (white blood cells) build up in different parts of the human body, resulting in a variety of symptoms. It is estimated that over 32,000 United States citizens could be living with this disease, and this webinar profiles what causes systemic mastocytosis, how this condition affects patients, how systemic mastocytosis can be detected and how are patients being treated for this disease.

Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258

•    A modified ProMisE algorithm was prognostic for recurrence free survival (RFS) and overall survival (OS).•    RFS seemed to be improved in patients with p53 wild type cancers who received chemoradiation in addition to chemotherapy.•    Patients who had tumors with abnormal p53 protein IHC had the worst RFS and OS compared to dMMR and p53 wild type cancers.